Testing a device to reduce freezing of gait in Parkinson’s
Part of Brain & nervous system clinical trials.
This study tests a device called cueStim to see if it can help people with Parkinson’s disease who experience freezing of gait (a sudden inability to move their feet). You may be able to join if you are between 60 and 90 years old, take levodopa, and can walk a short distance without help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 90 years old
- You have been diagnosed with idiopathic Parkinson’s disease by a doctor
- You can walk at least 12 meters (about 40 feet) without a walking aid (a cane is okay in daily life)
- You are taking levodopa and have not changed your Parkinson’s medications in the last 4 weeks
- You score at least 22 on a thinking and memory test called MoCA
- You have not used a cueing device (like a rhythmic beeper or vibration device) in the past 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new device called Cue2Walk can help people with Parkinson's disease who have freezing of gait. The device detects when you freeze and sends a signal (like a beep) to help you start walking again. Researchers want to see if it is worth the cost compared to your usual care.
This trial tests whether a spinal cord stimulator can reduce freezing of gait (feeling stuck when walking) in people with Parkinson's disease. It may help you if you have daily freezing episodes and are willing to have a small device implanted.
This study tests if deep brain stimulation (DBS) can improve 'freezing of gait' — sudden stops or trouble starting to walk — that continues even with Parkinson's medications. It might help people whose walking problems are their main symptom and aren't helped by drugs or standard DBS.
This study tests a brain-computer interface device to help people with Parkinson's disease who experience freezing of gait. The goal is to see if the device can reduce freezing episodes when medication isn't enough.
This trial tests a noninvasive ultrasound treatment targeting a brain area called the pedunculopontine nucleus to help reduce freezing of gait (a sudden inability to walk) in Parkinson's disease. If you have Parkinson's and experience freezing, you may be eligible to try this new approach.
This study looks at how a special brain pacemaker (called the Medtronic Percept device) affects walking problems like freezing of gait in people with Parkinson's. It aims to help understand and improve treatment.
Hear when a new Parkinson's Disease With Freezing of Gait trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.